|
EUROPLAN is to promote and implement National Plans or Strategies to tackle rare diseases, to share relevant experiences within Countries, linking national efforts with a common strategy at European level. This “double-level” approach ensures that progress is globally coherent and follows common orientations throughout Europe. EUROPLAN I has elaborated agreed tools for the development and implementation of National Plans following the Council Recommendation. Its contuniation, EUROPLAN II, is to establish an international and interactive network of stakeholders (mainly policy makers) to speed up the elaboration and the implementation of Rare Diseases National Plans, trough scientific and technical assistance, and the active participation of patients. EUROPLAN has really increased the capacity building of participants, has supported Countries with different geographical and economical concerns and different states of readiness for plan delivery by sharing experiences, disseminating successful practices. Finally, it has also identified feasible EUROPLAN indicators to monitor progress of different rare diseases activities.
|